Comparison of ChromID C. difficile agar and cycloserine-cefoxitinfructose agar for the recovery of Clostridium difficile

Pathology

Volumn 45, Issue 5, 2013, Pages 495-500

  Boseiwaqa, Lusiana V ^a   Foster, Niki F ^a   Thean, Sara K ^b   Squire, Michele M ^a   Riley, Thomas V ^a,b   Carson, Kerry C ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

ChromID; Chromogenic agar; Clostridium difficile; Isolation medium

Indexed keywords

AGAR; ALCOHOL; CEFOXITIN; CYCLOSERINE; FRUCTOSE;

ARTICLE; CHEMISTRY; CLASSIFICATION; CLOSTRIDIUM DIFFICILE; COMPARATIVE STUDY; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; PSEUDOMEMBRANOUS COLITIS; RIBOTYPING; TEMPERATURE; TIME;

AGAR; CEFOXITIN; CLOSTRIDIUM DIFFICILE; CYCLOSERINE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ETHANOL; FRUCTOSE; HUMANS; MICROBIOLOGICAL TECHNIQUES; RIBOTYPING; TEMPERATURE; TIME FACTORS;

EID: 84887886110     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e3283632680     Document Type: Article

References (35)

1. O'Connor JR, Johnson S, Gerding DN. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 2009; 136: 1913-24.
2. Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005; 366: 1079-84.
3. Goorhuis A, Bakker D, Corver J, et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 2008; 47: 1162-70.
4. van den Berg RJ, Claas ECJ, Oyib DH, et al. Characterization of toxin Anegative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping. J Clin Microbiol 2004; 42: 1035-41.
5. Freeman J, Bauer MP, Baines SD, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 2010; 23: 529-49.
6. Kim H, Riley TV, Kim M, et al. Increasing prevalence of toxin A-negative, toxin B-positive isolates of Clostridium difficile in Korea: impact on laboratory diagnosis. J Clin Microbiol 2008; 46: 1116-7.
7. Yan Q, Zhang J, Chen C, et al. Multilocus sequence typing (MLST) analysis of 104 Clostridium difficile strains isolated from China. Epidemiol Infect 2013; 141: 195-9.
8. Keel MK, Brazier JS, Post KW, Weese S, Songer JG. Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves and other species. J Clin Microbiol 2007; 45: 1963-4.
9. Rodriguez-Palacios A, Stampfli H, Duffield T, et al. Clostridium difficile PCR ribotypes in calves, Canada. Emerg Infect Dis 2006; 12: 1730-6.
10. Bakker D, Corver J, Harmanus C, et al. Relatedness of human and animal Clostridium difficile PCR Ribotype 078 isolates determined on the basis of multilocus variable-number tandem-repeat analysis and tetracycline resistance. J Clin Microbiol 2010; 48: 3744-9.
11. Debast SB, Van Leengoed LAMG, Goorhuis A, et al. Clostridium difficile PCR ribotype 078 toxinotype V found in diarrhoeal pigs identical to isolates from affected humans. Environ Microbiol 2009; 11: 505-11.
12. Rupnik M, Widmer A, Zimmermann O, et al. Clostridium difficile toxinotype V, ribotype 078, in animal and humans. J Clin Microbiol 2008; 46: 2146-.
13. Bauer MP, Notermans DW, van Benthem BHB, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2010; 377: 63-73.
14. Limbago BM, Long CM, Thompson AD, et al. Clostridium difficile strains from community-associated infections. J Clin Microbiol 2009; 47: 3004-7.
15. Gerding DN, Broom C, Gelone SP. Clostridium difficile infection: results of an international web-based surveillance project. Infect Dis Clin Pract 2009; 17: 161-8.
16. Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009; 7: 526-36.
17. Kvach EJ, Ferguson D, Riska PF, Landry ML. Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection. J Clin Microbiol 2010; 48: 109-14.
18. Larson AM, Fung AM, Fang FC. Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile. J Clin Microbiol 2010; 48: 124-30.
19. Novak-Weekley SM, Marlowe EM, Miller JM, et al. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms. J Clin Microbiol 2010; 48: 889-93.
20. Cohen SH, Gerding DN, Stuart Johnson, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31: 431-55.
21. George WL, Sutter VL, Citron D, Finegold SM. Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol 1979; 9: 214-9.
22. Levett P. Effect of antibiotic concentration in a selective medium on the isolation of Clostridium difficile from faecal specimens. J Clin Pathol 1985; 38: 233-4.
23. Wilson KH, Kennedy MJ, Fekety FR. Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile. J Clin Microbiol 1982; 15: 443-6.
24. Marler LM, Siders JA, Wolters LC, et al. Comparison of five cultural procedures for isolation of Clostridium difficile from stools. J Clin Microbiol 1992; 30: 514-6.
25. Perry JD, Asir K, Halimi D, et al. Evaluation of a chromogenic culture medium for isolation of Clostridium difficile within 24 hours. J Clin Microbiol 2010; 48: 3852-8.
26. Asir K, Bourguignon M-P, Halimi D, et al. Method for detecting and/or identifying Clostridium difficile. United States Patent US 2010/0279330 A1, issued Nov 4, 2010.
27. Ghosh S, Zhang P, Li Yq, Setlow P. Superdormant spores of Bacillus species have elevated wet-heat resistance and temperature requirements for heat activation. J Bacteriol 2009; 191: 5584-91.
28. Gould G, editor. Spore Germination. New York: Academic Press, 1969.
29. Gould GW. Germination and the problem of dormancy. J Appl Microbiol 1970; 33: 34-49.
30. Rodriguez-Palacios A, LeJeune JT. Moist-heat resistance, spore aging, and superdormancy in Clostridium difficile. Appl Environ Microbiol 2011; 77: 3085-91.
31. Naaber P, Stsepetova J, Smidt I, et al. Quantification of Clostridium difficile in antibiotic-associated-diarrhea patients. J Clin Microbiol 2011; 49: 3656-8.
32. Foster N, Riley TV. Improved recovery of Clostridium difficile spores with the incorporation of synthetic sodium taurocholoate in cyclo- serinecefoxitin-fructose agar (CCFA). Pathology 2012; 44: 354-6.
33. Eckert C, Burghoffer B, Lalande V, Barbut F. Evaluation of the Chromogenic Agar chromID C. difficile. J Clin Microbiol 2013; 51: 1002-4.
34. Hill K, Collins J, Wilson L, et al. Comparison of two selective media for the recovery of Clostridium difficile from environmental surfaces. J Hosp Infect 2013; 83: 164-6.
35. Jump RLP, Pultz MJ, Donskey CJ. Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea? Antimicrob Agent Chemother 2007; 51: 2883-7.